mobile background
NEUMED RESEARCH & DEVELOPMENT
R&D
iMED OVERVIEW

TRANSLATING KOREAN MEDICINE KNOWLEDGE INTO FUNCTIONAL INGREDIENTS

iMED PLATFORM

iMED is NeuMed’s proprietary R&D platform that interprets the knowledge system of Korean medicine and herbal pharmacology as modern scientific research hypotheses and translates them into functional ingredients through accurate raw material sourcing, purpose-specific extraction and standardization, and scientific data validation. Traditional knowledge accumulated over a long period does not become a product on its own. Through iMED, NeuMed transforms the knowledge of traditional prescriptions and medicinal herbs into modern research questions, verifies the identity of raw materials and the consistency of extracts, and builds experimental models and data that can validate functionality and safety. Beginning with traditional knowledge and continuing through materials, extraction, and data, the iMED platform has served as the foundation for the development of NeuMed’s functional ingredients, including HT042.

iMED OVERVIEW 

TRANSLATING KOREAN MEDICINE KNOWLEDGE
INTO FUNCTIONAL INGREDIENTS

iMED RESEARCH 
TECHNOLOGY

From Natural Wisdom to Scientific Validation

i
i
INTERPRETATION

TECHNOLOGY FOR TRANSLATING KOREAN MEDICINE KNOWLEDGE INTO RESEARCH HYPOTHESES 


NeuMed interprets the principles of Korean medicine, including the relationships among herbs in traditional prescriptions, as modern research hypotheses for functional ingredient development.

M
M
MATERIAL

TECHNOLOGY FOR SECURING RAW MATERIALS WITH VERIFIED ORIGIN AND QUALITY 


NeuMed verifies the identity and quality of raw materials through literature review, morphological identification, chemical analysis, DNA-based species identification, and voucher specimen management.

E
E
EXTRACT

PURPOSE-SPECIFIC EXTRACTION AND STANDARDIZATION TECHNOLOGY


NeuMed designs extraction methods suited to each raw material and development purpose, and standardizes extracts through component profiling and marker compound analysis.

D
D
DATA

TECHNOLOGY FOR VALIDATING FUNCTIONALITY THROUGH SCIENTIFIC DATA 


NeuMed builds evaluation models suited to each development purpose and validates functionality through component analysis, efficacy evaluation, safety review, preclinical studies, and human studies.

iMED PLATFORM

iMED is NeuMed’s proprietary R&D platform that interprets the knowledge system of Korean medicine and herbal pharmacology as modern scientific research hypotheses and translates them into functional ingredients through accurate raw material sourcing, purpose-specific extraction and standardization, and scientific data validation.

Traditional knowledge accumulated over a long period does not become a product on its own. Through iMED, NeuMed transforms the knowledge of traditional prescriptions and medicinal herbs into modern research questions, verifies the identity of raw materials and the consistency of extracts, and builds experimental models and data that can validate functionality and safety.

Beginning with traditional knowledge and continuing through materials, extraction, and data, the iMED platform has served as the foundation for the development of NeuMed’s functional ingredients, including HT042.


iMED RESEARCH
TECHNOLOGY

From Natural Wisdom to Scientific Validation

i
i
INTERPRETATION 

TECHNOLOGY FOR TRANSLATING
KOREAN MEDICINE KNOWLEDGE
INTO RESEARCH HYPOTHESES 

NeuMed interprets the principles of Korean medicine, including the relationships among herbs in traditional prescriptions, as modern research hypotheses for functional ingredient development.

M
M
MATERIAL

TECHNOLOGY FOR SECURING
RAW MATERIALS WITH VERIFIED
ORIGIN AND QUALITY 

NeuMed verifies the identity and quality of raw materials through literature review, morphological identification, chemical analysis, DNA-based species identification, and voucher specimen management.

E
E
EXTRACT 

PURPOSE-SPECIFIC EXTRACTION
AND STANDARDIZATION
TECHNOLOGY 

NeuMed designs extraction methods suited to each raw material and development purpose, and standardizes extracts through component profiling and marker compound analysis.

D
D
DATA

TECHNOLOGY FOR VALIDATING
FUNCTIONALITY THROUGH
SCIENTIFIC DATA 

NeuMed builds evaluation models suited to each development purpose and validates functionality through component analysis, efficacy evaluation, safety review, preclinical studies, and human studies.

COMPANY : NEUMED, Inc / CEO : Hocheol Kim 
TEL : +82-2-564-9140 / FAX : +82-2-564-9290

MAIL : sales@neumed.co.krBUSINESS LICENSE : 204-81-77134
ADD : 6F, 88 Imun-ro, Dongdaemun-gu, Seoul, Republic of Korea

4F, Seongsu SK V1 CENTER I, 48 Achasan-ro 17-gil, Seongdong-gu, Seoul, Republic of Korea

ⓒ 2026 NEUMED. ALL RIGHTS RESERVED.

COMPANY : NEUMED, Inc / CEO : Hocheol Kim 
TEL : +82-2-564-9140 / FAX : +82-2-564-9290

MAIL : sales@neumed.co.kr
BUSINESS LICENSE : 204-81-77134
ADD : 6F, 88 Imun-ro, Dongdaemun-gu,
Seoul, Republic of Korea

4F, Seongsu SK V1 CENTER I, 48 Achasan-ro
17-gil, Seongdong-gu, Seoul, Republic of Korea 

ⓒ 2026 NEUMED. ALL RIGHTS RESERVED.